Vir Biotechnology, Inc. · NASDAQ:VIR
Hatfield Jeffrey S. received 8,000 Vir Biotechnology, Inc. shares as an award (Form 4)
Traded May 27, 2026 · Filed May 28, 2026
On May 27, 2026, Hatfield Jeffrey S. (Director) received 8,000 Vir Biotechnology, Inc. shares as an award, leaving 39,806 shares. Filed May 28, 2026 (Form 4).
- Awarded
- 8,000 shares
- Holding after
- 39,806 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 27, 2026 | Common Stock | Award | 8,000 | 39,806 | Direct |
Source
Related
- Vir Biotechnology, Inc.
- Hatfield Jeffrey S.
- Vir Biotechnology, Inc. shareholders
- Form 4 · More Robert J · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · Coughlin Timothy · Jun 10, 2026
- Form 4 · Napolitano Janet · Jun 2, 2026